Search research articles
Contact Us
Filters
Showing results (1-10 of 58) with videos related to
Page
of 6
Sort By:
The Journal of Infection
|
February 19, 2013
Tuberculosis: time for a new perspective?
Paul T Elkington
Respiratory Investigation
|
February 28, 2024
Cancer immunotherapy with immune checkpoint inhibitors and infections: A particular focus on mycobacterial infections
Kohei Fujita, Paul T Elkington
The Lancet. Infectious Diseases
|
September 1, 2015
Permutations of time and place in tuberculosis
Paul T Elkington, Jon S Friedland
Methods in Molecular Biology (Clifton, N.J.)
|
April 7, 2009
Analysis of matrix metalloproteinase secretion by macrophages
Paul T Elkington, Justin A Green, Jon S Friedland
Bio-Protocol
|
September 15, 2017
Bioelectrospray Methodology for Dissection of the Host-pathogen Interaction in Human Tuberculosis
Liku B Tezera, Magdalena K Bielecka, Paul T Elkington
European Journal of Immunology
|
April 10, 2008
Monocyte-dependent oncostatin M and TNF-alpha synergize to stimulate unopposed matrix metalloproteinase-1/3 secretion from human lung fibroblasts in tuberculosis
Cecilia M O'Kane, Paul T Elkington, Jon S Friedland
Science Translational Medicine
|
February 25, 2011
Tuberculosis immunopathology: the neglected role of extracellular matrix destruction
Paul T Elkington, Jeanine M D'Armiento, Jon S Friedland
American Journal of Respiratory and Critical Care Medicine
|
April 10, 2014
Tuberculosis, pulmonary cavitation, and matrix metalloproteinases
Catherine W M Ong, Paul T Elkington, Jon S Friedland
Thorax
|
May 16, 2020
Tuberculosis associated with Triplet therapy for lung cancer
Danielle Crawley, Ronan A Breen, Paul T Elkington, et al.
Thorax
|
October 5, 2021
Infections due to dysregulated immunity: an emerging complication of cancer immunotherapy
Tommaso Morelli, Kohei Fujita, Gil Redelman-Sidi, et al.
Page
of 6
Search research articles
Search
Showing results (1-10 of 58) with videos related to
Sort By:
Page
of 6
The Journal of Infection
|
February 19, 2013
Tuberculosis: time for a new perspective?
Paul T Elkington
Respiratory Investigation
|
February 28, 2024
Cancer immunotherapy with immune checkpoint inhibitors and infections: A particular focus on mycobacterial infections
Kohei Fujita, Paul T Elkington
The Lancet. Infectious Diseases
|
September 1, 2015
Permutations of time and place in tuberculosis
Paul T Elkington, Jon S Friedland
Methods in Molecular Biology (Clifton, N.J.)
|
April 7, 2009
Analysis of matrix metalloproteinase secretion by macrophages
Paul T Elkington, Justin A Green, Jon S Friedland
Bio-Protocol
|
September 15, 2017
Bioelectrospray Methodology for Dissection of the Host-pathogen Interaction in Human Tuberculosis
Liku B Tezera, Magdalena K Bielecka, Paul T Elkington
European Journal of Immunology
|
April 10, 2008
Monocyte-dependent oncostatin M and TNF-alpha synergize to stimulate unopposed matrix metalloproteinase-1/3 secretion from human lung fibroblasts in tuberculosis
Cecilia M O'Kane, Paul T Elkington, Jon S Friedland
Science Translational Medicine
|
February 25, 2011
Tuberculosis immunopathology: the neglected role of extracellular matrix destruction
Paul T Elkington, Jeanine M D'Armiento, Jon S Friedland
American Journal of Respiratory and Critical Care Medicine
|
April 10, 2014
Tuberculosis, pulmonary cavitation, and matrix metalloproteinases
Catherine W M Ong, Paul T Elkington, Jon S Friedland
Thorax
|
May 16, 2020
Tuberculosis associated with Triplet therapy for lung cancer
Danielle Crawley, Ronan A Breen, Paul T Elkington, et al.
Thorax
|
October 5, 2021
Infections due to dysregulated immunity: an emerging complication of cancer immunotherapy
Tommaso Morelli, Kohei Fujita, Gil Redelman-Sidi, et al.
Page
of 6